PMVP — PMV Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $90.03m
- -$113.03m
- 34
- 49
- 51
- 41
Annual cashflow statement for PMV Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.4 | -34.4 | -57.8 | -73.3 | -69 |
| Depreciation | |||||
| Non-Cash Items | 0.978 | 2.23 | 6.84 | 9.81 | 6.62 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.92 | -0.845 | 4.12 | -0.568 | 5.43 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -22.1 | -32.7 | -46.6 | -63.8 | -55.7 |
| Capital Expenditures | -0.109 | -0.148 | -1.35 | -7.98 | -0.962 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.34 | 28.1 | -142 | 6.62 | -49.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 3.23 | 27.9 | -144 | -1.37 | -50.5 |
| Financing Cash Flow Items | -0.168 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 61.8 | 293 | 2.02 | 0.958 | 35.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 43 | 288 | -188 | -64.2 | -70.6 |